To dissect the biological role of praja2 in GBM, we first analyzed the expression profile of praja2 in 20 human glioma biopsies of patients undergoing brain surgery, which were previously characterized for the presence/absence of IDH1 mutations. This evidence concerns the gene IDH1 and glioblastoma.